Literature DB >> 20956568

Generation of a neutralizing human monoclonal antibody Fab fragment to surface antigen 1 of Toxoplasma gondii tachyzoites.

Yong-Feng Fu1, Meng Feng, Kenji Ohnishi, Tamon Kimura, Johbu Itoh, Xun-Jia Cheng, Hiroshi Tachibana.   

Abstract

A combinatorial immunoglobulin gene library was constructed from lymphocytes in peripheral blood of a patient with toxoplasmosis and screened for production of human monoclonal antibody Fab fragments to recombinant surface antigen 1 (SAG1) of Toxoplasma gondii. Two Fab clones, Tox203 and Tox1403, which consisted of a common heavy chain and different light chains, showed positive staining on the entire surface of tachyzoites in confocal microscopy. Sequence analysis of the heavy-chain gene revealed that the closest germ line V segments were VH3-23. The germ line D segment was D1-7, and the closest germ line J segment was JH4. In the light-chain genes, the closest germ line V segment was Vκ1-17 with the Jκ1 or Jκ4 segments. The dissociation constants of these Fab fragments with recombinant SAG1 were 3.09 × 10(-9) M for Tox203 and 2.01 × 10(-8) M for Tox1403, indicating that the affinity of Tox203 was 7 times higher than that of Tox1403. Preincubation of T. gondii tachyzoites with Tox203 significantly inhibited their attachment to cultured MDBK cells. Passive immunization of mice with Tox203 also significantly reduced mortality after challenge with T. gondii tachyzoites. This is the first report of bacterial expression of human monoclonal antibody Fab fragments to SAG1 of T. gondii. These results also demonstrate that human Fab fragments to SAG1 might be applicable for immunoprophylaxis of toxoplasmosis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20956568      PMCID: PMC3019919          DOI: 10.1128/IAI.00969-10

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  37 in total

1.  The conformation of purified Toxoplasma gondii SAG1 antigen, secreted from engineered Pichia pastoris, is adequate for serorecognition and cell proliferation.

Authors:  R Biemans; D Grégoire; M Haumont; A Bosseloir; L Garcia; A Jacquet; C Dubeaux; A Bollen
Journal:  J Biotechnol       Date:  1998-12-11       Impact factor: 3.307

2.  Toxoplasma gondii: the role of parasite surface and secreted proteins in host cell invasion.

Authors:  J Grimwood; J E Smith
Journal:  Int J Parasitol       Date:  1996-02       Impact factor: 3.981

3.  Functional expression and germline transmission of a human chromosome fragment in chimaeric mice.

Authors:  K Tomizuka; H Yoshida; H Uejima; H Kugoh; K Sato; A Ohguma; M Hayasaka; K Hanaoka; M Oshimura; I Ishida
Journal:  Nat Genet       Date:  1997-06       Impact factor: 38.330

4.  Attachment of Toxoplasma gondii to host cells involves major surface protein, SAG-1 (P30).

Authors:  J R Mineo; L H Kasper
Journal:  Exp Parasitol       Date:  1994-08       Impact factor: 2.011

5.  Recombinant Toxoplasma gondii surface antigen 1 (P30) expressed in Escherichia coli is recognized by human Toxoplasma-specific immunoglobulin M (IgM) and IgG antibodies.

Authors:  D Harning; J Spenter; A Metsis; J Vuust; E Petersen
Journal:  Clin Diagn Lab Immunol       Date:  1996-05

6.  Antibodies to Toxoplasma gondii major surface protein (SAG-1, P30) inhibit infection of host cells and are produced in murine intestine after peroral infection.

Authors:  J R Mineo; R McLeod; D Mack; J Smith; I A Khan; K H Ely; L H Kasper
Journal:  J Immunol       Date:  1993-05-01       Impact factor: 5.422

7.  Human antibodies elicited by a pneumococcal vaccine express idiotypic determinants indicative of V(H)3 gene segment usage.

Authors:  J Abadi; J Friedman; R A Mageed; R Jefferis; M C Rodriguez-Barradas; L Pirofski
Journal:  J Infect Dis       Date:  1998-09       Impact factor: 5.226

8.  Immunization with E. coli produced recombinant T. gondii SAG1 with alum as adjuvant protect mice against lethal infection with Toxoplasma gondii.

Authors:  E Petersen; H V Nielsen; L Christiansen; J Spenter
Journal:  Vaccine       Date:  1998-08       Impact factor: 3.641

9.  Human monoclonal anti-HCMV neutralizing antibody from phage display libraries.

Authors:  M Takekoshi; F Maeda; H Tachibana; H Inoko; S Kato; I Takakura; T Kenjyo; S Hiraga; Y Ogawa; T Horiki; S Ihara
Journal:  J Virol Methods       Date:  1998-09       Impact factor: 2.014

10.  Toxoplasma gondii surface antigen-1 in sera of HIV-infected patients as an indicator of reactivated toxoplasmosis.

Authors:  M F Letillois; V Laigle; F Santoro; M Micoud; B F Chumpitazi
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1995-10       Impact factor: 3.267

View more
  5 in total

1.  Characterization of a lipopolysaccharide-targeted monoclonal antibody and its variable fragments as candidates for prophylaxis against the obligate intracellular bacterial pathogen Coxiella burnetii.

Authors:  Ying Peng; Laura Schoenlaub; Alexandra Elliott; William J Mitchell; Guoquan Zhang
Journal:  Infect Immun       Date:  2014-08-11       Impact factor: 3.441

2.  Production, characterization and applications for Toxoplasma gondii-specific polyclonal chicken egg yolk immunoglobulins.

Authors:  Álvaro Ferreira Júnior; Fernanda M Santiago; Murilo V Silva; Flávia B Ferreira; Arlindo G Macêdo Júnior; Caroline M Mota; Matheus S Faria; Hercílio H Silva Filho; Deise A O Silva; Jair P Cunha-Júnior; José R Mineo; Tiago W P Mineo
Journal:  PLoS One       Date:  2012-07-12       Impact factor: 3.240

Review 3.  Recent advances in Toxoplasma gondii immunotherapeutics.

Authors:  Sherene Swee-Yin Lim; Rofina Yasmin Othman
Journal:  Korean J Parasitol       Date:  2014-12-23       Impact factor: 1.341

4.  Toxoplasma gondii Elongation Factor 1-Alpha (TgEF-1α) Is a Novel Vaccine Candidate Antigen against Toxoplasmosis.

Authors:  Shuai Wang; Zhenchao Zhang; Yujian Wang; Javaid A Gadahi; Lixin Xu; Ruofeng Yan; Xiaokai Song; Xiangrui Li
Journal:  Front Microbiol       Date:  2017-02-13       Impact factor: 5.640

Review 5.  Treatment of toxoplasmosis: Current options and future perspectives.

Authors:  Neda Konstantinovic; Hélène Guegan; Tijana Stäjner; Sorya Belaz; Florence Robert-Gangneux
Journal:  Food Waterborne Parasitol       Date:  2019-04-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.